Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-18

FDA Approved: EFAVIRENZ — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for EFAVIRENZ from Aurobindo Pharma Limited, authorizing changes to the approved ANDA product (such as formulation, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

SUPPL AP for EFAVIRENZ (EFAVIRENZ)